Skip to main content

Digital Therapeutics Market to Explore 20.8% of CAGR Growth by 2025

Press release   •   Apr 03, 2019 20:43 IST

Digital Therapeutics Market

The global digital therapeutics market is segmented into application, distribution channel, and geography. The digital therapeutics market is segmented into diabetes, cardiovascular disease, central nervous system disease, respiratory diseases, smoking cessation, musculoskeletal disease and others, by application. Based on the distribution channel, the market is classified as patients, providers, payers, and employers.

Diabetes is one of the most prevalent medical conditions, owing to various factors. Accordingly, there has been an increase in the awareness regarding diabetes among the population across the globe. However, there is still large amount of population unaware of having diabetes, due to presence of less symptoms. As per a data published IDF Diabetes Atlas - 8th Edition, around 212.4 million people or half (50.0%) of all people between the age group 20-79 years with diabetes are estimated to be unaware of their disease.

Get Sample data tables and in-depth TOC of the Digital Therapeutics Market (2018–2015) @

Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application (Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, Others); Distribution Channel (Patients, Providers, Payers, and Employers) and Geography

Major Players Operating in the Digital Therapeutics Market-
1. Propeller Health
3. Noom, Inc.
4. 2Morrow Inc.
5. Livongo Health
6. Proteus Digital Health
7. WellDoc, Inc.
8. Fitbit, Inc.
9. Omada Health, Inc.

People with undiagnosed diabetes have a higher usage of healthcare services compared to people without diabetes, and consequently likely to incur larger healthcare expenditures. With almost half the population being unaware of having diabetes, there is an urgent need to screen, diagnose as well as provide suitable care to people with diabetes. The rise in the number of undiagnosed diabetes cases are expected to mainly due to dearth in adequate screening facilities in low as well as high income countries.

Get 10% Free Customization on Purchase @

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment


By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.